Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alessandra I.G. Buma"'
Publikováno v:
Tumor Biology. :1-11
The optimal positioning and usage of serum tumor markers (STMs) in advanced non-small cell lung cancer (NSCLC) care is still unclear. This review aimed to provide an overview of the potential use and value of STMs in routine advanced NSCLC care for t
Autor:
Paul Baas, Vincent van der Noort, Rianne de Vries, Marguerite Wolf-Lansdorf, Michel M van den Heuvel, Peter J. Sterk, Alessandra I.G. Buma, Niloufar Farzan, Mirte Muller
Publikováno v:
Lung Cancer, 160, pp. 36-43
Lung Cancer, 160, 36-43
Lung cancer (Amsterdam, Netherlands), 160, 36-43. Elsevier Ireland Ltd
Lung Cancer, 160, 36-43
Lung cancer (Amsterdam, Netherlands), 160, 36-43. Elsevier Ireland Ltd
Objectives Exhaled breath analysis by electronic nose (eNose) has shown to be a potential predictive biomarker before start of anti-PD-1 therapy in patients with non-small cell lung carcinoma (NSCLC). We hypothesized that the eNose could also be used
Autor:
Peter J. Sterk, Paul Baas, Alessandra I.G. Buma, Vincent van der Noort, Mirte Muller, Niloufar Farzan, Michel M van den Heuvel, Marguerite Wolf-Lansdorf, Rianne de Vries
Publikováno v:
Lung Cancer. 162:211
Autor:
Buma, Alessandra I.G.1 (AUTHOR), Simmer, Femke1 (AUTHOR), den Braber‐Ymker, Marjanne1 (AUTHOR), Groenen, Patricia J.T.A.1 (AUTHOR) patricia.groenen@radboudumc.nl
Publikováno v:
APMIS. Sep2023, Vol. 131 Issue 9, p472-479. 8p.
Autor:
Buma, Alessandra I.G., Schuurbiers, Milou M.F., van Rossum, Huub H., van den Heuvel, Michel M.
Publikováno v:
Tumor Biology (IOS Press); 2024 Supplement, Vol. 46, pS207-S217, 11p
Publikováno v:
Cancer Weekly; 2/14/2023, p578-578, 1p